Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


Preferences help
enabled [disable] Abstract
Number of results
2013 | 25 | 100 | 112-118

Article title

SELECTIVE SEROTONIN REUPTAKE INHIBITORS – MEDICATIONS NOT ONLY FOR DEPRESSION

Content

Title variants

Languages of publication

EN

Abstracts

EN
Selective serotonin reuptake inhibitors (SSRIs) are the frontline class of antidepressant drugs. They are widely used because of their safety, tolerability, and demonstrated efficacy. In this review, we are pointing at other indications of SSRIs – apart from depression.This article is based on a selective review of the relevant literature retrieved by a PubMed search and ScienceDirect search. The results of electronic searches show SSRIs to be of great importance in pharmacotherapy of many conditions outside depression. Medical literature supports the use of SSRIs for the treatment of premature ejaculation (especially short-acting SSRI - dapoxetine), eating disorders (especially bulimia nervosa and binge eating disorder), obsessive-compulsive disorder and social anxiety disorder.

Year

Volume

25

Issue

100

Pages

112-118

Physical description

Contributors

author
  • Department of Pharmacological Screening, Chair of Pharmacodynamic Faculty of Pharmacy, Medical College, Jagiellonian University, Medyczna 9, 30-688 Kraków, Poland

References

Document Type

article

Publication order reference

Identifiers

YADDA identifier

bwmeta1.element.psjd-98c5115f-c383-4ee0-a3b1-3c629e1ab171
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.